ATH alterity therapeutics limited

Just playing with ChatGPT. An essential missing piece of...

  1. 3,074 Posts.
    lightbulb Created with Sketch. 1137
    Just playing with ChatGPT. An essential missing piece of information in the 201 and 202 studies is the effect on alpha-synuclein. We have positive animal studies, and hopefully, soon in the human studies.

    So here is my question to ChatGPT

    Does the iron content of the brain have a direct effect on alpha-synuclein accumulation?
    ChatGPT told:

    Yes, iron content in the brain does have a direct effect on alpha-synuclein accumulation, and this relationship is well-documented in the context of Parkinson’s disease (PD) and related synucleinopathies.

    Key Points of the Relationship:

    1. Iron Promotes Alpha-Synuclein Aggregation:

      • Iron can bind directly to alpha-synuclein at specific binding sites, notably at the N-terminus.

      • This binding enhances the aggregation of alpha-synuclein into toxic oligomers and fibrils.

      • In vitro studies have shown that ferric (Fe³⁺) iron accelerates the formation of fibrillar alpha-synuclein.

    2. Iron and Oxidative Stress:

      • Iron is a redox-active metal and participates in the Fenton reaction, producing reactive oxygen species (ROS).

      • Oxidative stress can cause post-translational modifications of alpha-synuclein (e.g., nitration or oxidation), which promote its aggregation.

      • ROS also damages cellular machinery responsible for clearing alpha-synuclein (like the proteasome and autophagy pathways), further contributing to its accumulation.

    3. Iron Dysregulation in Parkinson’s Disease:

      • Post-mortem studies of PD brains show elevated iron levels, especially in the substantia nigra, where dopaminergic neuron loss and alpha-synuclein aggregation are most severe.

      • Iron accumulation correlates with both alpha-synuclein pathology and neuronal degeneration.

    4. Therapeutic Implications:

      • Iron chelators like deferiprone have been studied in clinical trials and animal models as a strategy to reduce iron levels and slow alpha-synuclein aggregation and neurodegeneration.

      • These approaches show promise but also highlight the need to balance iron reduction without causing systemic iron deficiency.

    Summary:

    Yes, iron directly influences alpha-synuclein accumulation by binding to it, promoting its aggregation, and contributing to oxidative stress and impaired clearance. This relationship is central to the pathology of Parkinson’s disease and is an active area of research for potential therapies.

    Would you like references or diagrams illustrating this interaction?

    Sinä sanoit:
    An illustration would be nice, thanks:
    ChatGPT sanoi:
    Luotu kuva



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.5¢
Change
0.002(15.4%)
Mkt cap ! $138.1M
Open High Low Value Volume
1.4¢ 1.5¢ 1.4¢ $70.41K 5.037M

Buyers (Bids)

No. Vol. Price($)
2 95000 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 21150934 14
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.